Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Doxofylline (400mg) + Acebrophylline (100mg)
Therapeutic Category
Pulmonary, Respiratory
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dozyfyle AB Tablet Doxofylline 400 mg Acebrophylline 100 mg is a premium respiratory combination offering both effective bronchodilation and mucolytic action. Doxofylline works as a xanthine derivative to relax the bronchial muscles while Acebrophylline provides additional bronchodilation and helps thin and clear mucus offering complete management for chronic conditions like COPD and bronchial asthma.
The synergistic dual molecule combination provides superior symptomatic relief leading to strong physician preference and predictable revenue. COPD and asthma require long term treatment guaranteeing stable high-volume sales.
The product is primarily prescribed by Pulmonologists and Consulting Physicians securing a high-value specialist segment. The single tablet form improves patient adherence. Secure your exclusive Dozyfyle AB territory and capitalize on the rapidly growing chronic respiratory management market.
Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, or mild rash. Rarely, allergic reactions such as hives, swelling, or difficulty breathing may occur. Persistent or severe symptoms should prompt immediate medical consultation.
Moxyplit CV 457 Tablet is indicated for the treatment of bacterial infections, including respiratory tract infections (sinusitis, bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, otitis media, and dental infections. It is especially useful for infections caused by beta-lactamase-producing bacteria that are resistant to amoxicillin alone.
Take Moxyplit CV 457 Tablet exactly as prescribed by your healthcare provider. Disperse the tablet in a small amount of water before administration if required. Complete the full course of therapy even if symptoms improve early to prevent bacterial resistance. Patients allergic to penicillin or with a history of liver or kidney disorders should use this medication under strict medical supervision.
Store Moxyplit CV 457 Tablet in a cool, dry place below 25°C, protected from moisture and sunlight. Keep out of reach of children and discard any unused portion after the expiry date.
Composition : Tolperisone (150mg) + Paracetamol (325mg)
Composition : Thiocolchicoside (4mg) + Aceclofenac (100mg) + Paracetamol (325mg) Tablet
Composition : Tolperisone (150mg) + Diclofenac (50mg)
Composition : Tolperisone (450mg) + Diclofenac (100mg)
Composition : Trypsin I.P. 48mg + Bromelain B.P. 90mg + Rutoside Trihydrate B.P. 100mg + Diclofenac I.P. 50mg
Composition : Tamsulosin (0.4mg) + Dutasteride (0.5mg)
Composition : Silodosin (8mg) + Dutasteride (0.5mg)
Composition : Timolol (5mg) + Brimonidine (2mg) Eye Drop
Composition : Tobramycin (0.3% w/v) + Fluorometholone (0.1% w/v)
Composition : Tranexamic Acid (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This respiratory combination has strong demand in the asthma and COPD segment, making it a useful prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in chronic asthma, COPD, bronchitis, wheezing, chest congestion, and airway inflammation. It is widely prescribed by physicians and pulmonologists for long-term bronchodilation and mucolytic support.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Doxofylline 400mg SR + Acebrophylline 100mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady chronic prescription demand, strong hospital and clinic acceptance, and repeat seasonal sales when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.